Cargando…
Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor
BACKGROUND: Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven to be very effective in the management of type II diabetes. These medications can cause adverse drug reactions such as genital mycotic infections. Another critical adverse drug reaction is euglycemic diabetic ketoacidosis...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906987/ https://www.ncbi.nlm.nih.gov/pubmed/35282610 http://dx.doi.org/10.1155/2022/4101975 |